National and Kapodistrian University of Athens
Επαγωγἠ ανοχής του αυγού σε παιδιά με αλλεργία στο αυγό μέσω της εισαγωγής θερμικά επεξεργασμένης πρωτεΐνης αυγού στη διατροφή τους (με τη μορφή κέικ)
Abstract
dc:descriptionA major drawback of oral immunotherapy for food allergy is the possibility of severe adverse events. We assessed both efficacy and safety of a low allergenic hydrolysed egg preparation used in double-blind placebo-controlled randomized study in egg allergic children. Twenty-nine children recruited from 3 study sites in Europe (Greece, Switzerland and Italy) were admitted to the study. All fulfilled the inclusion criteria of being 1 – 5.5 years old, diagnosed with an IgE-mediated egg allergy based on a positive skin prick test (SPT) to egg white within the last 3 months as well as a positive oral challenge or a convincing history, defined as an immediate (<1h) reaction following isolated ingestion of egg and positive sIgE (>0.35 kU/L) for at least one of the following: egg, egg white, ovalbumin, ovomucoid, within the last 12 months. All ethics committees of the hospitals approved the study, and an informed consent was obtained from the parents of each child. The randomization to receive either double-blind oral immunotherapy with the placebo or with HydE (ratio 1:1) for 6 months was applied by using the software TrialSys (developed at Nestlé, Lausanne). Stratification was performed by gender (male or female), centre (Greece, Italy or Switzerland) and age (12-35 months or 36-66 months).All randomized subjects were included and analysed in the intention-to-treat group.HydE and placebo study products were packaged, labelled and stored at Eurofins, France. A study box containing 110 sachets of the randomized product was sent to the study site (and provided to the parents) directly after randomization of the child and a second identical box followed after 2.5 months. Each centre received at the start of the study “SPT kits“ containing each a sachet of HydE and a sachet of placebo. OFC to egg was performed after 6 months. All allergic children randomised to the HA egg tolerated the product. No statistically significant difference was observed on the final OFC (36% vs 21%) had a negative OFC in the treatment and the placebo groups respectively. Specific IgG4 increased in the active group, while both CD203+ and CD63+ basophil decreased significantly over time. More research is needed to improve effectiveness in this safe alternative for OIT to egg.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Giavi, Stavroula
- Γιαβή, Σταυρούλα
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38360